The Last Word: Dr. Adrian Denvir on Selecting Nine Startups for the HSC Next SBIR Phase 0 Program

Dallas Innovates
Written By Lindsey Settles

Read More

Lindsey Settles
Previous

Lantern Pharma Further Enhances Capabilities of its AI Drug Discovery Platform, RADR®, with Product Development Roadmap for the Development of Antibody Drug Conjugates
Next

Scenes from D CEO‘s and Dallas Innovates’ 2023 Innovation Awards